Lineage Cell Therapeutics Inc. (LCTX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Broadwood Capital

Neal C. Bradsher

34,005,379 $79,913 4.24%
2.
Two Sigma Advisors

John Overdeck And David Siegel

1,633,866 $3,840 +221% 0.01%
3.
Millennium Management

Israel Englander

1,425,776 $3,351 +302% 0%
4.
ExodusPoint Capital

Michael Gelband

334,197 $785 -59% 0.01%
5. 230,218 $541 +1557% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.00 0 Large Shareholder, Director 34,005,379 2019-08-15 Filing
$0.97 13,146 Large Shareholder, Director 34,005,379 2019-08-15 Filing
$0.00 0 Large Shareholder, Director 33,992,233 2019-08-14 Filing
$0.98 1,407 Large Shareholder, Director 33,992,233 2019-08-14 Filing
$0.00 0 Large Shareholder, Director 33,990,826 2019-08-13 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.93 19,142 Director 15,578 2021-06-29 Filing
$2.97 4,720 Director 87,500 2021-06-29 Filing
$2.23 6,000 Officer 0 2021-03-30 Filing
$2.80 150,000 Officer, Director 5,781,555 2017-07-31 Filing
$2.35 300,000 Large Shareholder, Officer, Director 5,638,055 2016-01-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 64,232 $183 0.06%
2. 29,000 $82 0.02%
3. 15,000 $43 0.01%
4. 12,499 $35 0.02%
5. 10,600 $30 0%
News See All